Edwards Lifesciences is driven by a passion to help patients. The company is dedicated to providing innovative solutions for people fighting cardiovascular disease.
As a global leader in heart valves and critical care monitoring, Edwards Lifesciences focuses on technologies for transcatheter heart valves, surgical heart valves, and transcatheter mitral and tricuspid therapies. The company is committed to advancing treatments for conditions like aortic stenosis through innovations such as TAVI (Transcatheter Aortic Valve Implantation).
Edwards Lifesciences also emphasizes corporate responsibility, environmental sustainability, and global health impact. The company supports charitable giving and community programs to improve patient outcomes worldwide.